Funder
National Institute of Health
Subject
Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology
Reference39 articles.
1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united states;Rahib;Cancer Res.,2014
2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris 3rd;J. Clin. Oncol.,1997
3. Metabolism and disposition of gemcitabine, and oncolytic deoxycytidine analog, in mice, rats, and dogs;Shipley;Drug Metab. Dispos.,1992
4. nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer;Frese;Cancer Discov.,2012
5. Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer;Awasthi;Carcinogenesis,2013
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献